SCHEMBL1016922

SCHEMBL1016922

COC(=O)c1cc(-c2ccc(F)cc2)ccc1NC(=O)COCC(=O)Nc1cc(-c2ccc(F)cc2)ccc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
LMNA P02545 2/20 0.43
HSD17B10 Q99714 5/20 0.43
KDM4E B2RXH2 3/20 0.43
MAPT P10636 3/20 0.43
RXFP1 Q9HBX9 1/20 0.43
TSHR P16473 3/20 0.41
TP53 P04637 1/20 0.41
USP2 O75604 1/20 0.41
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
HPGD P15428 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPC1 O15118 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015634 0.93 ALDH1A1 (0.53) ALDH1A1LMNAKDM4EMAPTRXFP1
SCHEMBL1016816 0.90 RXFP1 (0.46) ALDH1A1LMNAHSD17B10KDM4ERXFP1
SCHEMBL1016253 0.89 RXFP1 (0.45) ALDH1A1LMNAHSD17B10KDM4ERXFP1
SCHEMBL1014577 0.88 KDM4E (0.50) ALDH1A1HSD17B10KDM4EMAPTTSHR
SCHEMBL1016254 0.88 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10KDM4EMAPT
SCHEMBL1015626 0.83 RXFP1 (0.53) ALDH1A1LMNAHSD17B10KDM4EMAPT
SCHEMBL1014695 0.82 ALDH1A1 (0.53) ALDH1A1LMNAHSD17B10KDM4EMAPT
SCHEMBL1800596 0.82 ALDH1A1 (0.54) ALDH1A1HSD17B10KDM4EMAPTTSHR
SCHEMBL1796132 0.81 TSHR (0.47) ALDH1A1LMNAHSD17B10KDM4EMAPT
SCHEMBL1013557 0.81 ALDH1A1 (0.54) ALDH1A1LMNAKDM4EMAPTRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 ALDH1A1 888/4885LMNA 525/4885HSD17B10 1898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.